๐ฅ๐ฒ๐ด๐ถ๐๐๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐๐ผ ๐๐ต๐ฒ ๐๐๐๐ญ/๐ก๐๐ง/๐๐๐ง๐ ๐๐๐ฅ๐ฃ๐ข๐ข๐ก ๐ฐ๐ผ๐ป๐ณ๐ฒ๐ฟ๐ฒ๐ป๐ฐ๐ฒ 2025 ๐ถ๐ ๐ป๐ผ๐ ๐ผ๐ฝ๐ฒ๐ป! ๐
Hope to see many of you on Nov 27 + 28 at the HCC in Heidelberg...!
Please register here: indico.dkfz.de/event/1230/
07.08.2025 11:53 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0
๐ก JANE-2 welcomes the European Commissionโs Call for Evidence on the Data Union Strategy. This joint response reflects insights from 22+ Member States and includes 13 recommendations to support future EU Health Networks.
๐ Read the full response ๐ #JANE2 #EUHealth #CancerResearch #DataStrategy
29.07.2025 07:36 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0
YouTube video by Institut national du cancer
10 - Uniting across borders: enhancing cancer prognosis through global scientific collaboration
JANE-2 INITIATIVE AT THE G7 CANCER CONFERENCE
๐ค Ms. Agnieszka Janowska - WP5 Poor Prognosis Cancers- shared its goals and progress with an international audience.
๐บ Watch the replay here: youtu.be/gbWxcUPIpYc
#CancerResearch #G7Conference #JANE2Initiative #HealthInnovation
22.07.2025 13:27 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0
๐ฏ โInnovation only matters if it reaches those who need it.โ JANE2 WP5โ11 leaders are bridging science & care โ from Omics tech to survivor support. Their goal: accessible, equitable cancer care across Europe. #JANE2 #EU4Health #HealthUnion #EUagainstcancer
18.07.2025 11:33 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0
Omics tools are transforming cancer care โ but EU regulations must catch up. JANE2 calls for smarter, faster HTA frameworks to avoid delays, support innovation, and ensure equal access for patients across Europe. ๐งฌ #JANE2 #EUagainstCancer #HealthUnion #EU4Health ๐ Link to report: lnkd.in/dAY4cCnQ
09.07.2025 13:30 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0
JANE2 WP11 advances AYA cancer care in Europe: governance set, SIOPE โ25 policy input, mapping & AYA guidelines underway. #EU4Health
08.07.2025 13:08 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0
First brainstorming meeting of the Policy Board of Joint Action JANE-2: networks of networks.
In Europe, health means: Community; Addressing diversity; Promoting equity; Delivering results.
#EU4Health#HealthUnion#EUCancerPlan
jane-2.eu/participants/
01.07.2025 07:51 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
JANE2 continues to shape the future of cancer prevention, gathering top experts to create an impactful approach.
Delia Nicoara and Stefania Boccia, leaders of the WP8 pointed out how JANE2 is set to pave the way towards a personalised cancer care across Europe
#HealthUnion#EU4Health#EUCancerPlan
27.02.2025 08:29 โ ๐ 4 ๐ 1 ๐ฌ 0 ๐ 0
JANE2 continues to shape the future of cancer prevention, gathering top experts to create an impactful approach.
Delia Nicoara and Stefania Boccia, leaders of the WP8 pointed out how JANE2 is set to pave the way towards a personalised cancer care across Europe
#HealthUnion#EU4Health#EUCancerPlan
27.02.2025 08:29 โ ๐ 4 ๐ 1 ๐ฌ 0 ๐ 0
Professors Julie Gehl & Jean Yves Blay, co-leaders of the Hi-Tech Medical Resources NoEs (WP10), shared their central priority in relation with #JANE2 initiative:
Ensuring that all cancer patients across Europe have access to specialized Hi-tech medical services
#HealthUnion#EUCancerPlan#EU4Health
24.02.2025 19:23 โ ๐ 4 ๐ 1 ๐ฌ 0 ๐ 0
Professors Julie Gehl & Jean Yves Blay, co-leaders of the Hi-Tech Medical Resources NoEs (WP10), shared their central priority in relation with #JANE2 initiative:
Ensuring that all cancer patients across Europe have access to specialized Hi-tech medical services
#HealthUnion#EUCancerPlan#EU4Health
24.02.2025 19:23 โ ๐ 4 ๐ 1 ๐ฌ 0 ๐ 0
Andrรฉs Morales, leader of the Expertise in Survivorship NoEs(WP7), signaled his key points:
๐คActing on the complex needs of cancer survivors
๐ขBuilding Networks of Networks for a robust oncology landscape
๐Surviving is not the end of the journey, but the beginning
#HealthUnion#EUCancerPlan#EU4Health
19.02.2025 11:41 โ ๐ 3 ๐ 1 ๐ฌ 0 ๐ 0
Andrรฉs Morales, leader of the Expertise in Survivorship NoEs(WP7), signaled his key points:
๐คActing on the complex needs of cancer survivors
๐ขBuilding Networks of Networks for a robust oncology landscape
๐Surviving is not the end of the journey, but the beginning
#HealthUnion#EUCancerPlan#EU4Health
19.02.2025 11:41 โ ๐ 3 ๐ 1 ๐ฌ 0 ๐ 0
Andrea Ferrari & Salvatore Provenzano, co-coordinators of the AYA NoE (WP11), had an isighful exchange about the JANE2 project.
They mainly highlighted, the relevance of bridging the Gap between Pediatric and Adult Oncology.
#HealthUnion #EUCancerPlan #EU4Health
14.02.2025 12:21 โ ๐ 5 ๐ 1 ๐ฌ 0 ๐ 0
Hรฉlene Antoine-Poirel & Inge Smeers, shared their perspective on the JANE2 project.
As part of the Omics Work Package, they emphasized the importance of incorporating high-tech solutions as well as developing integrated models from prevention to survivorship.
#HealthUnion #EUCancerPlan #EU4Health
05.02.2025 14:38 โ ๐ 6 ๐ 2 ๐ฌ 0 ๐ 1
JANE2ยดs Network of Expertise on Poor Prognosis Cancer works to align practices, shape policies & foster innovation in Europe. From mapping gaps in care to supporting pilots & connecting researchers, it builds bridges to improve outcomes & share best practices๐
#HealthUnion #EU4Health #EUCancerPlan
29.01.2025 10:19 โ ๐ 6 ๐ 1 ๐ฌ 0 ๐ 0
JANE2 brings together clinicians, and researchers across Europe to support Adolescents & Young Adults with Cancer.
As a result, developing new pediatric and oncology frameworks and expanding specialized treatment across Europe, will be key priorities to JANE2.
#HealthUnion#EU4Health#EUCancerPlan
29.01.2025 08:43 โ ๐ 4 ๐ 1 ๐ฌ 0 ๐ 0
"Building networks that outlast projects is key. JANE-2 aims for equity in cancer care across the EU through subsidiarity & true cooperation. Itโs not just about research, but about transfering innovation to clinical practice"
Paolo Casali, JANE-2 Coordinator.
#HealthUnion #EU4Health #EUCancerPlan
28.01.2025 09:59 โ ๐ 6 ๐ 2 ๐ฌ 0 ๐ 0
Today we celebrate the JANE2 Kick-Off Event.
In his opening speech, Olivรฉr Vรกrhelyi, European Commissar for Health, has highlighted how JANE2, an initiative involving up to 29 european nations, plays a key role in Europe's commitment against cancer.
#EU4Health #EUCancerPlan #HealthUnion #JANE2๐ช๐บ
28.01.2025 08:34 โ ๐ 6 ๐ 2 ๐ฌ 0 ๐ 0
When? Tomorrow at 9AM.
Where? Milan, Italy.
Why? To protect and improve the lives of European patients and citizens.
What? The JANE2 Inaugural Event.
Tomorrow, the largest European Joint Action focused on cancer will kick off.
Stay tuned! ๐ช๐บ๐งฌ๐ฅ
#HealthUnion #EU4Health #EUCancerPlan
27.01.2025 18:56 โ ๐ 5 ๐ 0 ๐ฌ 0 ๐ 0
Furthermore, we would like to express our deepest gratitude to our institutional host, the Fundazione IRCCS - Istituto Nazionale dei Tumori.
24.01.2025 11:53 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
We are pleased to announce that Milan will host the JANE2 Kick-Off event (Jan28th&29th).
This event will reunite some of the most relevant stakeholders in the fields of innovative cancer treatments and cancer-focused research.
You will be able to follow it through our social media.
So stay tuned!
24.01.2025 11:47 โ ๐ 3 ๐ 0 ๐ฌ 1 ๐ 0
Chromatin and cancer research at UNC Chapel Hill. Opinions are my own. Raab-lab.org
Official account of the Mackall Lab @Stanford. Discovering principles that control tumor:immune interactions to develop immunotherapies for pediatric cancer
Cancer researcher @NKI_nl and @oncodeinstitute, Cofounder of Flindr Tx; developing rational cancer & immune cell combination treatments using functional genomics
The Netherlands Cancer Institute (NKI): at the international forefront of cancer research and treatment for over 100 years.
Professor of Cancer Cell and Metastasis Biology. CRUK Senior Fellow. Institute of Cancer Research. London.
https://www.icr.ac.uk/our-research/researchers-and-groups/professor-victoria-sanz-moreno
Leads the Melanoma Laboratory at the Spanish National Cancer Centre (CNIO). Board member of ASEICA. Activist for woman in science and for young investigators. Cancer patient advocate.
We are a world-leading cancer research institute dedicated to improving patient lives through discovery science.
Core funded by Cancer Research UK, part of the University of Cambridge.
www.cruk.cam.ac.uk
Leads the Cancer Stem Cells & Metastasis Lab @HMar_research | focused in breast cancer immunotherapy
http://celiaterrassalab.com
We're a partnership between The University of Manchester, Cancer Research UK and The Christie NHS Foundation Trust.
Est: 2006
Director: Professor Rob Bristow
๐ฅ๏ธ https://www.mcrc.manchester.ac.uk/
Evolution and cancer research @icrlondon.bsky.social.
Interests include:
drug resistance
pre-malignancy and early detection
epigenetics
plasticity
population genetics
microbiome
lineage tracing
biotech
Director @trevorgraham.bsky.social
The Metastasis Research Society (MRS) is dedicated to supporting progressive metastatic cancer research with the goal of improving treatments and patient lives.
http://www.metastasis-research.org
Chancellor's Fellow at Institute of Genetics and Cancer, Edinburgh. Chromosomal instability, dynamics of structural variation in tumours. Lead a statistical cancer genomics ๐งฌ group. Beaches, trees + mountains ๐๏ธ๐ฒ๐๏ธ Currently on maternity leave.
NUCancer opened in 2019 to bring together >100 cancer and cancer-related researchers from across the three faculties of Newcastle University. We are focused on world leading cancer discovery research and its translation to new oncology therapeutics.
Director, Centre for Evolution and Cancer @cec-icr.bsky.social at @icr.ac.uk
Genomics, epigenetics, evolution, mathematical modelling, data science, bowel cancer
Associate Professor at University of Barcelona. Breast Cancer Group Leader at IDIBELL.
Cientรญfico empeรฑado en entender el cรกncer y en favorecer la ciencia en nuestro paรญs. Trabajo en el Centro de Investigaciรณn del Cรกncer de Salamanca. RTโ endorsement
Inter-dimensional cancer biologist. Director of the @genomescience.bsky.social at @umbaltimore.bsky.social.
Associate Professor | UNC Chapel Hill, Pharmacology Department | Lineberger Comprehensive Cancer Center | Research in Endocrinology, Epigenetics, & Wnt signaling| Views my own. https://www.med.unc.edu/pharm/pruittlab/team/
Postdoc at Memorial Sloan Kettering Cancer Center, New York | Fascinated by cancer cell plasticity, tumor microenvironment, immunology and therapy resistance
Sigrid Jusรฉlius Professor, Translational Cancer Medicine Program & Department of Biochemistry and Developmental Biology, University of Helsinki, Finland. #cancer #genomics #transcription #chromatin